[1]
N. A. Gumán and F. De La Hoz, “Cost effectiveness of heptavalent pneumococcal conjugate vaccine in populations of high risk in Colombia”, Colomb Med, vol. 41, no. 4, pp. 315–322, Jan. 2011.